Resistance to activated protein C (APC) is the most common risk factor for venous thromboembolism, a major cause of morbidity and mortality with an incidence of about 1/1,000 per year. The Arg 506 to Gln mutation in exon 10 of the coagulation factor V gene (factor V-Leiden) has been found to be resp
An evaluation of the Factor V Leiden mutation in a cohort of African-American pregnant women
β Scribed by Nancy C. Rose; Y. Lynn Wang; A. George Neubert; Nancy W. Roth; Mengrong Li; Robert B. Wilson
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 32 KB
- Volume
- 18
- Category
- Article
- ISSN
- 0197-3851
No coin nor oath required. For personal study only.
β¦ Synopsis
The objective of this work was to study the prevalence of the Factor V Leiden mutation in an obstetrical clinic largely comprised of African-American women. A cross-sectional study was performed evaluating a total of 231 consecutive women of African-American origin. Of these patients, 21 were considered at high risk for thrombosis, but none was found to carry the mutation. One patient (0β’4 per cent) of the total was heterozygous for the Factor V Leiden mutation. African-American women do not appear to be at an increased risk of being heterozygous or homozygous for the Leiden mutation. This low prevalence may be confounded by ascertainment bias in a population of pregnant women. 1998 John Wiley & Sons, Ltd.
π SIMILAR VOLUMES
## Abstract Congenital disorders of glycosylation (CDG) are a group of metabolic disorders with multisystemic involvement characterized by abnormalities in the synthesis of Nβlinked oligosaccharides. The most common form, CDGβIa, resulting from mutations in the gene encoding the enzyme phosphomanno